You are invited to attend a press briefing at the European Association for the Study of Diabetes (EASD) 1999
Tuesday 28 September 1999, 18.30 - 20:00,
Ambassador Room, 1st Floor, Hall 10
Brussels Exhibition and Conference Centre
What is the cost of type 2 diabetes in Europe?
How do different countries compare?
Are current management strategies effective?
Why is insulin resistance important?
Could new approaches save lives and money?
CODE-2* is the first pan-European study to evaluate the economic impact of type 2 diabetes on society.
-
8 European countries
Over 600 physicians
Over 7000 patients
The press briefing, hosted by members of CODE-2* Advisory Boards, will launch the results of this landmark study and discuss the implications of CODE-2* for the future treatment of type 2 diabetes.
The following CODE-2* experts will speak at the briefing:
- Professor Massimo Massi-Benedetti
Chair of the International Diabetes Foundation (Europe Region), Italy - Professor Bengt Jönsson
Stockholm School of Economics, Sweden - Dr Andreas Liebl
Staedtisches Krankenhaus Bogenhausen, Germany - Dr Robert Young
Hope Hospital, Salford, UK
To confirm your attendance at the briefing, please contact Barbara Campbell,
Susie Hackett or Kate Davies on: Tel: 44-171-404-7151
Email:
barbarac@meditech.co.uk
kate@meditech.co.uk
susie@meditech.co.uk
SmithKline Beecham Pharmaceuticals -- Advancing Diabetes Care
*Trademark of SmithKline Beecham plc (CODE-2: Costs of Diabetes in Europe -- Type 2)